| 1 | [SID103755918] | Active | Ki | 0.0085 | Displacement of [3H](S)-N-(2-(1H-pyrrol-1-yl)phenyl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX2R expressed in CHO cells after 3 hrs by scintillation counting [AID482635, Type: Literature] | Orexin receptor type 2 [gi:206729885] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103755918 | | CID | 46868793 | | Outcome | Active | | Ki | 0.0085 [uM] | | BioAssay | Displacement of [3H](S)-N-(2-(1H-pyrrol-1-yl)phenyl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX2R expressed in CHO cells after 3 hrs by scintillation counting | | AID | 482635 | | BioAssay type | Literature | | Target | Orexin receptor type 2 [gi:206729885] | | PubMed | 20565075 | | Data Table |  |
|
| 2 | [SID103755918] | Active | Ki | 0.0085 | Displacement of [3H](S)-N-(2-(1H-pyrrol-1-yl)phenyl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX2R expressed in CHO cells after 3 hrs by scintillation counting [AID482635, Type: Literature] | Orexin receptor type 2 [gi:206729885] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103755918 | | CID | 46868793 | | Outcome | Active | | Ki | 0.0085 [uM] | | BioAssay | Displacement of [3H](S)-N-(2-(1H-pyrrol-1-yl)phenyl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX2R expressed in CHO cells after 3 hrs by scintillation counting | | AID | 482635 | | BioAssay type | Literature | | Target | Orexin receptor type 2 [gi:206729885] | | PubMed | 20565075 | | Data Table |  |
|
| 3 | [SID103755918] | Active | Ki | 0.054 | Displacement of [3H](S)-N-(biphenyl-2-yl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX1R expressed in CHO cells after 3 hrs by scintillation counting [AID482633, Type: Literature] | Orexin receptor type 1 [gi:205804177] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103755918 | | CID | 46868793 | | Outcome | Active | | Ki | 0.054 [uM] | | BioAssay | Displacement of [3H](S)-N-(biphenyl-2-yl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX1R expressed in CHO cells after 3 hrs by scintillation counting | | AID | 482633 | | BioAssay type | Literature | | Target | Orexin receptor type 1 [gi:205804177] | | PubMed | 20565075 | | Data Table |  |
|
| 4 | [SID103755918] | Active | Ki | 0.054 | Displacement of [3H]N-cyclobutyl-5-methyl-N-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)ethyl)-2-(2H-1,2,3-triazol-2-yl)benzamide from human OX1R expressed in CHO cells after 20 hrs by scintillation counting [AID482634, Type: Literature] | Orexin receptor type 1 [gi:205804177] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103755918 | | CID | 46868793 | | Outcome | Active | | Ki | 0.054 [uM] | | BioAssay | Displacement of [3H]N-cyclobutyl-5-methyl-N-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)ethyl)-2-(2H-1,2,3-triazol-2-yl)benzamide from human OX1R expressed in CHO cells after 20 hrs by scintillation counting | | AID | 482634 | | BioAssay type | Literature | | Target | Orexin receptor type 1 [gi:205804177] | | PubMed | 20565075 | | Data Table |  |
|
| 5 | [SID103755918] | Active | Ki | 0.054 | Displacement of [3H](S)-N-(biphenyl-2-yl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX1R expressed in CHO cells after 3 hrs by scintillation counting [AID482633, Type: Literature] | Orexin receptor type 1 [gi:205804177] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103755918 | | CID | 46868793 | | Outcome | Active | | Ki | 0.054 [uM] | | BioAssay | Displacement of [3H](S)-N-(biphenyl-2-yl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX1R expressed in CHO cells after 3 hrs by scintillation counting | | AID | 482633 | | BioAssay type | Literature | | Target | Orexin receptor type 1 [gi:205804177] | | PubMed | 20565075 | | Data Table |  |
|
| 6 | [SID103755918] | Active | Ki | 0.054 | Displacement of [3H]N-cyclobutyl-5-methyl-N-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)ethyl)-2-(2H-1,2,3-triazol-2-yl)benzamide from human OX1R expressed in CHO cells after 20 hrs by scintillation counting [AID482634, Type: Literature] | Orexin receptor type 1 [gi:205804177] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103755918 | | CID | 46868793 | | Outcome | Active | | Ki | 0.054 [uM] | | BioAssay | Displacement of [3H]N-cyclobutyl-5-methyl-N-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)ethyl)-2-(2H-1,2,3-triazol-2-yl)benzamide from human OX1R expressed in CHO cells after 20 hrs by scintillation counting | | AID | 482634 | | BioAssay type | Literature | | Target | Orexin receptor type 1 [gi:205804177] | | PubMed | 20565075 | | Data Table |  |
|